[{"figure_path": "tsIKrvexBd/tables/tables_7_1.jpg", "caption": "Table 1: C-index (mean \u00b1 std) over five cancer datasets. The best and second-best results are highlighted in bold and underlined.", "description": "This table presents the concordance index (C-index), a measure of the accuracy of survival prediction models, for five different cancer types (BRCA, LGG, LUAD, COAD, PAAD) using various methods, including the proposed ProtoSurv model.  The C-index is reported as the mean and standard deviation across five-fold cross-validation.  The best and second-best performing methods for each cancer type are highlighted.", "section": "5.3 Comparison with State-Of-The-Art Methods"}, {"figure_path": "tsIKrvexBd/tables/tables_8_1.jpg", "caption": "Table 2: Ablation study of the main modules in ProtoSurv.", "description": "This table presents the ablation study results for the main modules of the ProtoSurv model: Histology View (HV), Structure View (SV), and Prior Guided Fusion & Pooling (PGF).  It shows the C-index (mean \u00b1 std) achieved by different model variations across five cancer datasets (PAAD, BRCA, LGG, LUAD, COAD), demonstrating the contribution of each module and the effectiveness of the proposed PGF module in combining the features from the other two modules.", "section": "5.5 Ablation Studies"}, {"figure_path": "tsIKrvexBd/tables/tables_8_2.jpg", "caption": "Table 3: Effect of different classifiers.", "description": "This table presents the results of ProtoSurv using different patch classifiers: CONCH, HoverNet, Pre-Proto, and K-means with varying cluster numbers (4, 6, 8).  The C-index (mean \u00b1 std) is reported for five different cancer types (PAAD, BRCA, LGG, LUAD, COAD), demonstrating the model's robustness to various patch classification approaches.", "section": "5.5 Ablation Studies"}, {"figure_path": "tsIKrvexBd/tables/tables_9_1.jpg", "caption": "Table 4: Effect of tissue category choices.", "description": "This table presents the results of the ProtoSurv model using three different tissue category settings: Detailed Tissue Category (DTC), Coarse Tissue Category (CTC), and Prior Tissue Category (PTC).  The PTC setting uses tissue categories selected based on prior knowledge of prognosis-related tissues. The table shows the C-index (mean \u00b1 std) achieved by the model under each tissue category setting across five different cancer datasets (PAAD, BRCA, LGG, LUAD, COAD). This demonstrates the impact of incorporating prior knowledge about relevant tissue types in improving the model's performance.", "section": "5.5 Ablation Studies"}, {"figure_path": "tsIKrvexBd/tables/tables_14_1.jpg", "caption": "Table 5: Effects of GCN layer number in Structure View.", "description": "This table presents the ablation study results of using different numbers of layers (all, last, last two) in the Structure View of the ProtoSurv model.  The C-index (mean \u00b1 std) for survival prediction performance is shown for five different cancer types (PAAD, BRCA, LGG, LUAD, COAD). It demonstrates how the number of layers used to extract features from the Structure View affects the model's performance.", "section": "5.5 Ablation Studies"}, {"figure_path": "tsIKrvexBd/tables/tables_15_1.jpg", "caption": "Table 6: Effects of classification errors.", "description": "This table presents the ablation study results on the impact of classification errors on the overall performance.  It shows the C-index (mean \u00b1 std) for ProtoSurv and two variations: 20% and 30% of node categories are randomly generated.  The results demonstrate the model's robustness against classification errors.", "section": "5.5 Ablation Studies"}, {"figure_path": "tsIKrvexBd/tables/tables_15_2.jpg", "caption": "Table 7: Effects of compatibility and orthogonality losses.", "description": "This ablation study evaluates the impact of compatibility loss (Lcomp) and orthogonality loss (Lortho) on the model's performance across five cancer datasets (PAAD, BRCA, LGG, LUAD, COAD).  Different hyperparameter settings for \u03b1 (Lcomp) and \u03b2 (Lortho) were tested, ranging from 0 to 0.1. The results show that incorporating both losses consistently improves the model's performance compared to using only the Cox loss.", "section": "5.5 Ablation Studies"}, {"figure_path": "tsIKrvexBd/tables/tables_16_1.jpg", "caption": "Table 8: Computational requirements.", "description": "This table presents the computational resource usage of the proposed model, ProtoSurv, its lightweight version, ProtoSurv-tiny, and the baseline model, PatchGCN.  Metrics include inference time, floating point operations (FLOPs), model parameters (in millions), and maximum GPU memory usage (in MB).  The results provide a quantitative comparison of the computational efficiency across different models.", "section": "5.3 Comparison with State-Of-The-Art Methods"}, {"figure_path": "tsIKrvexBd/tables/tables_16_2.jpg", "caption": "Table 9: Performance of ProtoSurv-tiny.", "description": "This table presents the performance of the ProtoSurv-tiny model (a smaller version of the main model) across five different cancer datasets (PAAD, BRCA, LGG, LUAD, COAD).  The results are presented as C-index (mean \u00b1 standard deviation).  The C-index measures the accuracy of the model in predicting survival time ranking.", "section": "5.3 Comparison with State-Of-The-Art Methods"}]